TP53 and breast cancer: Furthermore, the presence of mutations in TP53 can be a predictor of chemo-resistance in breast cancer [77,78] including neoadjuvant chemotherapy; however, larger prospective studies are needed to further analyze its role as a potential therapeutic target in breast cancer as well as other cancers [79].